IDEXX Laboratories Inc
NASDAQ:IDXX
IDEXX Laboratories Inc
NASDAQ:IDXX
Price:
487.07 USD
0.7%
Market Closed
Updated:
May 9, 2024
IDEXX Laboratories Inc
Cash from Operating Activities
|
IDEXX Laboratories Inc
Cash from Operating Activities Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
Cash from Operating Activities
$921.2m
|
CAGR 3-Years
7%
|
CAGR 5-Years
18%
|
CAGR 10-Years
14%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Cash from Operating Activities
$3.4B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Cash from Operating Activities
$2.5B
|
CAGR 3-Years
10%
|
CAGR 5-Years
40%
|
CAGR 10-Years
8%
|
|
|
Stryker Corp
NYSE:SYK
|
Cash from Operating Activities
$3.5B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
6%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Cash from Operating Activities
$7.1B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
4%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Cash from Operating Activities
$1.7B
|
CAGR 3-Years
2%
|
CAGR 5-Years
7%
|
CAGR 10-Years
8%
|
See Also
What is IDEXX Laboratories Inc's Cash from Operating Activities?
Cash from Operating Activities
921.2m
USD
921.2m
USD
Based on the financial report for Mar 31, 2024, IDEXX Laboratories Inc's Cash from Operating Activities amounts to 921.2m USD.
What is IDEXX Laboratories Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
14%
14%
Over the last year, the Cash from Operating Activities growth was 50%. The average annual Cash from Operating Activities growth rates for IDEXX Laboratories Inc have been 7% over the past three years , 18% over the past five years , and 14% over the past ten years .
You don't have any saved screeners yet
